Maxay Daawooyinkee Loogu Hortagi Karaa In Lagu Caawiyo Cudurka Cudurka Qaaxada iyo Cudurka Cagaarshow?
Sanadihii ugu dambeeyay, daaweynta cudurka wadnaha bararka (IBD) ayaa aad u soo jiidatay shirkadaha dawooyinka iyo cilmi baarayaasha. Mustaqbalka loogu talagalay dadka qaba IBD ayaa ah mid ka fiican sidii hore, maadaama daroogooyinka intooda badani ay ku jiraan dhuumaha si loo daaweeyo cudurada bukaanka ah iyo dhibaatooyinka la xiriira.
Alicaforsen
Alicaforsen hadda waxa ku jira shatiga ay bixiso farmashiyaha Atlantic Limited.
Daawada waxaa maamula mindhicirka waxaana lagu baarayaa isticmaalka ulcerative colitis iyo pouchitis . Alicaforsen ayaa la siiyay xaaladda daroogada agoonta ee Maraykanka iyo Midowga Yurub.
Alequel
Enzo Biochem ayaa dhameysatay daraasad ku saabsan Alequel ee bukaanada qaba cudurka Crohn ee dhexdhexaad ilaa daran. Daawada waa daaweyn shakhsi ahaaneed oo lagu soo saaro borotiin ku jirta oo laga sameeyay unug ka soo baxa bukaanka bukaanka oo afka laga qaato. Ka-fadhiisinta waxaa lagu gaaray 50 boqolkiiba bukaanka daawada, halka boqolkiiba 33 ay la socdaan koontarool. Daawada si fiican ayaa loo dulqaatay, iyada oo aan wax saameyn ah aan laheyn.
Daaweeyn
Xaruntan cusub ayaa loo baranayaa isticmaalka labadaba IBD iyo cilladda mindhicirka (SBS) . SBS waa xaalad keenta shuban, casiraad, gariir, iyo jooniska oo ku dhaca dadka qaba qeyb ka yar (ama ka badan) mindhicirka yar . Sababta ugu badan ee SBS waa soo noqnoqitaan qalliin oo loo isticmaalo daaweynta cudurka Crohn.
Dhibaatooyinka kale ee daawada loojuglutide ayaa u muuqda mid aad u yar, maaddaama ay saameyntu inta badan ku dhacaan xuubka mindhicirka. Dadka SBS ee ka qeyb qaatay tijaabada daawada iluklutide waxay muujiyeen labadaba nafaqada iyo miisaanka jirka. Caadooyinka caadiga ah ee la soo sheegay ayaa waxaa ka mid ah xanuunka caloosha, madax xanuun, isbeddellada stoma, iyo barar.
NPS Pharmaceuticals, soo-saaraha daawada cayayaanka, ayaa dhammeystiray baadhitaan caddayn oo ku saabsan bukaan-socodka qaba cudurka Crohn. Bukaannada qaba Crohn's, boqolkiiba 55 waxay ku guuleysteen ka dib markii 8 usbuuc ay isticmaaleen daroogada, marka la barbardhigo boqolkiiba 33 bukaanka qaata koontada. Waxyeellada ugu daran ee la soo sheegey ayaa ahaa guduudashada meesha ay cirbad tahay. Daraasad kale ayaa lagu qabtey bukaanka qaba SBS.
Teduglutide ayaa la siiyay xaaladda daroogada agoonta ee Maraykanka iyo Yurub labadaba isticmaalka SBS. NPS waxay hadda raadineysaa lamaane horumarineed si ay u sii wadaan tijaabinta daroogada si loogu isticmaalo cudurka Crohn.
Traficet-EN (CCX282)
Traficet-EN waa daaweyn yar-yar oo anti-neefqaade ah kaas oo iminka lagu baaro isticmaalka cudurrada Crohn ee ay soo saarto, ChemoCentryx. Maxkamadeynta ugu dambeysa (PROTECT-1), boqolkiiba dadka bukaanka ah ee qaata daawada lagaa helay muddada ka dib 36 toddobaad marka loo eego kuwii helay xuddunta. Daawada ayaa si fiican loogu dulqaatay ka qaybgalayaasha daraasadda intii lagu gudajiray tijaabadii 12 bilood.
Ilaha:
ChemoCentryx. "Barnaamijka CCR9." 2010. 26 Juun 2010.
Enzo Biochem, Inc. "Alequel." . 2010. 26 Juun 2010.
Isis Pharmaceuticals, Inc. "Cudurka Inflammatory." . 2010. 26 Juun 2010.
Margaret M, Israel E, Shibolet O, Zigmond E, Klein A, Hemed N, Donegan JJ, Rabbani E, Goldin E, Ilan Y. "Iskudhin laba-indho-indho-daaweyn ah oo loogu talagalay daaweynta Cudurka cudurrada Crohn ee ka yimaada maamulka afka ee Alequel, oo ka mid ah borotiinka xiidmiga uurka leh ee loo yaqaan 'autologous colon-extracted': waa hab bukaanka loo habeeyay. " Am J Gastroenterol Maarso 2006 101: 561-568. 26 Juunyo 2010.
NPS Pharmaceuticals. "Fursadaha Iskaashiga NPS." 2010. 26 Feb 2012.